Disease Tolerance during Viral-Bacterial Co-Infections

Area of Science:

• Immunology
• Pathology
• Virology

Background:

• Viral-bacterial co-infections, like influenza and Streptococcus pneumoniae, pose significant health risks.
• Disease tolerance is a host survival strategy distinct from resistance, focusing on mitigating damage rather than eliminating pathogens.
• Understanding tolerance mechanisms is crucial for managing severe co-infections.

Purpose of the Study:

• To review host cytokines and innate immune cells that mediate disease tolerance during viral-bacterial co-infection.
• To highlight mechanisms that promote tissue integrity and organ protection.
• To identify factors contributing to host homeostasis and survival.

Main Methods:

• Literature review of studies on host responses to viral-bacterial co-infections.
• Analysis of the roles of specific cytokines (e.g., IL-10, TGF-β) in disease tolerance.
• Examination of innate immune cell functions (e.g., macrophages, neutrophils) in mediating tolerance.

Main Results:

• Certain host cytokines and innate immune cells promote tissue protection and limit organ damage.
• Dysregulated immune responses can lead to immunopathology, increasing morbidity and mortality.
• Disease tolerance mechanisms are essential for restoring homeostasis and ensuring host survival.

Conclusions:

• Host cytokines and innate immune cells are key mediators of disease tolerance.
• Targeting these pathways offers a therapeutic strategy for co-infections.
• Promoting disease tolerance is vital for improving outcomes in complex infections.